Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 18.26 2.76% 0.49
RXRX closed up 2.76 percent on Monday, October 25, 2021, on 1.26 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical RXRX trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Wide Bands Range Expansion 0.00%
MACD Bearish Signal Line Cross Bearish 2.76%
New 52 Week Closing Low Bearish 2.76%
Hammer Candlestick Bullish 2.76%
Lizard Bullish Bullish Day Trade Setup 2.76%
New 52 Week Low Weakness 2.76%
Wide Bands Range Expansion 2.76%
Down 3 Days in a Row Weakness 2.76%
Older End-of-Day Signals for RXRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% about 15 hours ago
Possible NR7 about 16 hours ago
60 Minute Opening Range Breakout about 17 hours ago
Lizard Bullish Entry about 18 hours ago
Hammer Candlestick Entry about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pharmaceutical Industry Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Takeda Pharmaceutical Company Rare Monogenic Diseases

Is RXRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 42.81
52 Week Low 16.5301
Average Volume 659,710
200-Day Moving Average 0.00
50-Day Moving Average 22.39
20-Day Moving Average 19.79
10-Day Moving Average 18.84
Average True Range 1.85
ADX 29.85
+DI 10.49
-DI 27.77
Chandelier Exit (Long, 3 ATRs) 20.46
Chandelier Exit (Short, 3 ATRs) 22.07
Upper Bollinger Bands 23.04
Lower Bollinger Band 16.54
Percent B (%b) 0.26
BandWidth 32.84
MACD Line -1.52
MACD Signal Line -1.55
MACD Histogram 0.0274
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.68
Resistance 3 (R3) 19.56 18.96 19.44
Resistance 2 (R2) 18.96 18.60 19.02 19.36
Resistance 1 (R1) 18.61 18.38 18.79 18.73 19.28
Pivot Point 18.02 18.02 18.11 18.08 18.02
Support 1 (S1) 17.67 17.66 17.84 17.79 17.24
Support 2 (S2) 17.07 17.43 17.13 17.16
Support 3 (S3) 16.72 17.07 17.08
Support 4 (S4) 16.84